Periscope Capital’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Periscope Capital’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-158,500	Closed	-$1.6M	–	929
2022 Q4	$1.6M	Buy	158,500 +100,000	+171%	+$998K	0.07%	396
2022 Q3	$579K	Sell	58,500 -41,500	-42%	-$409K	0.02%	582
2022 Q2	$978K	Hold	100,000	–	–	0.03%	600
2022 Q1	$978K	Hold	100,000	–	–	0.03%	622
2021 Q4	$973K	Hold	100,000	–	–	0.03%	590
2021 Q3	$975K	Hold	100,000	–	–	0.03%	562
2021 Q2	$965K	Buy	+100,000	New	+$977K	0.03%	521

Periscope Capital's MSAC Position: Q1 2023 in Review

Periscope Capital sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 158,500 shares — an estimated $1.6M sold.

Periscope Capital first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $1.6M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Periscope Capital reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Periscope Capital sold 158,500 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $1.6M.
Periscope Capital first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Periscope Capital's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $1.6M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Periscope Capital's 13F filing for Q1 2023, filed 12 May 2023.